Healthy subjects
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy subjects Subjects who sign an informed consent form to participate in the study People who can exercise
Exclusion criteria
Exclusion criteria: People who have a history of heart disease, cardiovascular disease in the past, or who are currently undergoing treatment People who were judged difficult to exercise due to factors such as Injury at the start of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oxidative stress marker (TBARS, 8-isoprostane, d-ROMs, BAP in blood) | — |
Secondary
| Measure | Time frame |
|---|---|
| Amino acids (citrulline, ornithine, arginine) NOx (NO2 and NO3), SOD activity, catalase activity, arginase activity, mRNA and protein expressions of antioxidant-related gene (PGC-1a, SOD, CAT, GPX, NOX2, XOR, ARG1, ARG2, CARS2, SQOR), and metabolites in serum | — |
Countries
Japan
Contacts
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Public Health